# Kamau Therapeutics, Inc. — Form D

Kamau Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-03. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2025-06-03
- Form: D
- Accession: 0002071165-25-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 6
- Date of first sale: 2025-05-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-547903

## Issuer

- Name: Kamau Therapeutics, Inc.
- CIK: 0002071165
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 220 E. GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 628-333-5084

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Valentin Barsan | Director | South San Francisco, CA |
| Ness Bermingham | Director | South San Francisco, CA |
| Raymond Kelleher | Director | South San Francisco, CA |
| Matthew Porteus | Director | South San Francisco, CA |
| Valentin Barsan | Executive Officer | South San Francisco, CA |
| Matthew Porteus | Executive Officer | South San Francisco, CA |

## More

- [CIK 2071165 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2071165&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002071165-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.